Stay updated on Pembrolizumab vs Platinum-based Chemo in Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Platinum-based Chemo in Urothelial Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab vs Platinum-based Chemo in Urothelial Carcinoma Clinical Trial page
- Check5 days agoChange DetectedThe site footer now displays software revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check12 days agoChange DetectedA site-wide NIH notice about terminology during its website transition was added, and the footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.4%

- Check26 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision: v3.7.0 appears in the page history, replacing the previous v3.6.6 and signaling a new version of the study record history.SummaryDifference0.1%

- Check68 days agoChange DetectedA new revision tag v3.6.6 was added, replacing v3.6.5. This indicates an updated version of the page's history/revision, reflecting metadata rather than substantive content changes.SummaryDifference0.1%

- Check89 days agoChange DetectedRevision: v3.6.5 now appears in the record history, replacing the previous v3.6.4 and indicating a software version update for the page. This change does not modify the study data or the content of the history listings.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs Platinum-based Chemo in Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Platinum-based Chemo in Urothelial Carcinoma Clinical Trial page.